Clinical trials: Endogenous Hyperinsulinism

Endogenous Hyperinsulinism

Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia

• Completed
• Age: 18 years and older
• Injection or infusion

This study is to evaluate the concept of the exenatide test for diagnosis of EHH (earlier induction of symptomatic hypoglycemia compared to placebo within 4 hours after injection).

Trial name

FAST (NCT04909333)

Testing

Exenatide, 0.9% saline solution

Where

Switzerland

Volunteers

29 people

Sponsor

University Hospital, Basel, Switzerland